9+1AI Earns FDA Breakthrough Device Designation for AI-Driven ECG-Based BNP Estimation Tool for Early Heart Failure Detection
This precise, non-invasive screening tool is designed for patients with or at risk for heart failure and is intended to support earlier identification of cardiac dysfunction in a variety of care environments.
Read more